Is OrganiGram Stock a Buy After British American Tobacco's Investment?

OrganiGram (NASDAQ: OGI) leaped into the spotlight recently on the news that British American Tobacco (NYSE: BTI) bought a big stake in the Canadian marijuana company. 

In this video captured from Motley Fool Live on March 12, veteran Fool contributor Eric Volkman and healthcare and cannabis bureau chief Corinne Cardina discuss whether OrganiGram is a now a buy in the wake of that deal.

 

Continue reading

Source Fool.com